Reporting quality of Cochrane systematic reviews with Chinese herbal medicines

Table 4 Reporting quality of 27 items of PRISMA (n = 109 SRs)

Category	Item	Score, n (%)
Title	1. Title	0 (0%)^a
Abstract	2. Structured summary	109 (100)
Introduction	3. Rationale	109 (100)
Introduction	4. Objective	109 (100)
Methods RESULTS	5. Protocol and registration	106 (97.2)
	6. Eligibility criteria	109 (100)
	7. Information sources	106 (97.2)
	8. Search	85 (78.0)
	9. Study selection	108 (99.1)
	10. Data collection process	107 (98.2)
	11. Data items	60 (55.0)
	12. Risk of bias in individual studies	108 (99.1)
	13. Summary measures	109 (100)
	14. Synthesis of results	107 (98.2)
	15. Risk of bias across studies	83 (76.1)
	16. Additional analyses	94 (86.2)
	17. Study selection	107 (98.2)
	18. Study characteristics	109 (100)
	19. Risk of bias within studies	109 (100)
	20. Results of individual studies	109 (100)
	21. Synthesis of results	109 (100)
	22. Risk of bias across studies	79 (72.5)
	23. Additional analysis	59 (54.1)
Discussion	24. Summary of evidence	109 (100)
	25. Limitations	83 (76.1)
	26. Conclusions	109 (100)
Funding	27. Funding	94 (86.2)

^aNot applicable. The format of titles in Cochrane SRs is not required to include the words of “systematic review” or “meta-analysis”

ISSN: 2046-4053